日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Streptococcus pyogenes serotype M12 33 kDa chaperonin (hslO) CSB-YP629472SAAV
CSB-EP629472SAAV
CSB-BP629472SAAV
CSB-MP629472SAAV
CSB-EP629472SAAV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M12 Translation initiation factor IF-1 (infA) CSB-YP629473SAAV
CSB-EP629473SAAV
CSB-BP629473SAAV
CSB-MP629473SAAV
CSB-EP629473SAAV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M12 50S ribosomal protein L2 (rplB) CSB-YP629474SAAV
CSB-EP629474SAAV
CSB-BP629474SAAV
CSB-MP629474SAAV
CSB-EP629474SAAV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine UPF0553 protein C9orf64 homolog CSB-YP629475BO
CSB-EP629475BO
CSB-BP629475BO
CSB-MP629475BO
CSB-EP629475BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Abhydrolase domain-containing protein 16A (ABHD16A), partial CSB-YP629476BO1
CSB-EP629476BO1
CSB-BP629476BO1
CSB-MP629476BO1
CSB-EP629476BO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Uncharacterized protein C2orf50 homolog CSB-YP629477BO
CSB-EP629477BO
CSB-BP629477BO
CSB-MP629477BO
CSB-EP629477BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio DEP domain-containing protein 7 (depdc7), partial CSB-YP629478DIL
CSB-EP629478DIL
CSB-BP629478DIL
CSB-MP629478DIL
CSB-EP629478DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Dolichol-phosphate mannosyltransferase (DPM1) CSB-YP629479BO
CSB-EP629479BO
CSB-BP629479BO
CSB-MP629479BO
CSB-EP629479BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Tetraspanin-15 (TSPAN15), partial CSB-YP629480BO1
CSB-EP629480BO1
CSB-BP629480BO1
CSB-MP629480BO1
CSB-EP629480BO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Immediate early response 3-interacting protein 1 (IER3IP1), partial CSB-YP629481BO1
CSB-EP629481BO1
CSB-BP629481BO1
CSB-MP629481BO1
CSB-EP629481BO1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine PDZ domain-containing protein GIPC2 (GIPC2) CSB-YP629482BO
CSB-EP629482BO
CSB-BP629482BO
CSB-MP629482BO
CSB-EP629482BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cell division protein ZapA (zapA) CSB-YP629483ENL
CSB-EP629483ENL
CSB-BP629483ENL
CSB-MP629483ENL
CSB-EP629483ENL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rana versabilis Temporin-1V CSB-YP629484RAAS
CSB-EP629484RAAS
CSB-BP629484RAAS
CSB-MP629484RAAS
CSB-EP629484RAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora crassa Inosine triphosphate pyrophosphatase (B20D17.150, NCU01441) CSB-YP629485NHA
CSB-EP629485NHA
CSB-BP629485NHA
CSB-MP629485NHA
CSB-EP629485NHA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora crassa Probable zinc metalloprotease NCU04133 (9G6.250, NCU04133), partial CSB-YP629486NHA
CSB-EP629486NHA
CSB-BP629486NHA
CSB-MP629486NHA
CSB-EP629486NHA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Probable E3 ubiquitin protein ligase C167.07c (SPAC167.07c, SPAC57A7.03c), partial CSB-YP629487SXV
CSB-EP629487SXV
CSB-BP629487SXV
CSB-MP629487SXV
CSB-EP629487SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Takifugu rubripes Homeobox protein Hox-D4b (hoxd4b) CSB-YP629488TKY
CSB-EP629488TKY
CSB-BP629488TKY
CSB-MP629488TKY
CSB-EP629488TKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Takifugu rubripes Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (pde11a), partial CSB-YP629489TKY
CSB-EP629489TKY
CSB-BP629489TKY
CSB-MP629489TKY
CSB-EP629489TKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Takifugu rubripes Protein lunapark-A (lnpa), partial CSB-YP629490TKY
CSB-EP629490TKY
CSB-BP629490TKY
CSB-MP629490TKY
CSB-EP629490TKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Takifugu rubripes Major facilitator superfamily domain-containing protein 5 (mfsd5), partial CSB-YP629491TKY
CSB-EP629491TKY
CSB-BP629491TKY
CSB-MP629491TKY
CSB-EP629491TKY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×